Caregivers Press For Experimental Alzheimer's Drug
Jason Karlawish, professor of medical ethics, University of Pennsylvania
A medical study published in Science finds that an FDA-approved skin cancer drug can reduce Alzheimer's-like symptoms in mice. It is unclear if the drug, marketed as Targretin, will have the same effect on humans. Some researchers want to begin testing the drug for its efficacy in treating Alzheimer's patients.
la galaxy jordy nelson hot chelle rae guile alton brown weather los angeles caleb hanie